Magnesium hydroxide is an over-the-counter compound applied across domains where additional symptomatic support is needed, primarily serving as both an antacid and a saline laxative. This dual functionality is considered relevant in contexts involving episodic or fluctuating manifestations of gastrointestinal discomfort.

The compound is considered relevant for easing symptoms associated with two therapeutic areas. These include managing occasional constipation and providing relief for heartburn, acid indigestion, and upset stomach. As a laxative, it is applied in addressing occasional constipation. This generally assists with maintaining functional stability during episodes where symptoms related to physical discomfort create noticeable physiological strain.

Separately, as an antacid, it is relevant for easing symptoms that interfere with daily functioning, such as those that become temporarily overwhelming during phases of increased distress or discomfort. This contributes to easing the overall symptom load and helps improve day-to-day comfort during symptomatic periods. The medicine is generally used in settings marked by temporary physiological imbalance.

“This compound is considered relevant for easing symptoms associated with two therapeutic areas.”

---

Quick Fact: Relevant Clinical Context

Quick Fact: Used for Managing Acute Symptom Patterns (Often used during phases when symptoms become more noticeable, it may help patients cope more steadily with symptom fluctuations.)

Regulatory References

1. NIH MedlinePlus Drug Information

Population Eligibility for Magnesium Hydroxide PSM

Official regulatory documents define strict criteria for who can and cannot use Magnesium Hydroxide PSM, based on age, physiological status, and underlying medical conditions.

Absolute Contraindications

Magnesium Hydroxide is contraindicated and must not be used by patients with severe renal failure or severe kidney impairment due to the high risk of magnesium accumulation (hypermagnesaemia). Use is also strictly prohibited in patients with hypersensitivity to magnesium salts or those with signs of acute gastrointestinal conditions, including intestinal obstruction, faecal impaction, or suspected appendicitis.

Age-Based and Conditional Restrictions

Use is generally established for adults and children 12 years of age and over. For children under 12 years, eligibility is restricted and requires consultation with a health professional, particularly for antacid use. Children under six years old also require medical guidance for use as a laxative.

Conditional use is mandated for several populations. Individuals with non-severe renal impairment, those on a magnesium-restricted diet, and pregnant or breastfeeding individuals are all required to ask a health professional before use. Caution is also advised for the elderly and those with impaired liver function.

Magnesium Hydroxide can affect the action of many other oral medicines, primarily by altering the amount absorbed into the body. This occurs because the product, acting as an antacid and multivalent cation, can either increase gastric pH or bind to the other medicine in the digestive tract.

Impact on Co-Administered Medicines

• Decreased Absorption: The absorption and effectiveness of several drug classes may be significantly reduced. These include certain antibiotics (e.g., tetracyclines, fluoroquinolones like ciprofloxacin), Bisphosphonates, Digoxin, and Iron supplements. This reduction requires a specific action to mitigate the interaction risk.
• Altered Excretion: The alkaline environment created by the medicine in the body may also modify the rate at which certain drugs are eliminated, such as increasing the excretion of salicylates.

Risk Mitigation

To minimize the risk of a significant interaction, it is generally recommended to separate the dose of other orally taken medicines from Magnesium Hydroxide by an interval of at least 2 to 3 hours.

Renal Function Constraint

Use is cautioned in individuals with impaired renal function (kidney problems). Since magnesium is eliminated by the kidneys, reduced function increases the risk of hypermagnesaemia (high magnesium levels) and potential toxicity, which may require dose adjustment.

How Magnesium Hydroxide PSM Works: Mechanism of Action

Magnesium Hydroxide exerts its actions through two distinct, peripheral mechanistic domains localized entirely within the gastrointestinal tract.

---

Direct Chemical Neutralization of Luminal Acid

This domain covers the Mg( OH)2's action as a direct chemical base that rapidly interacts with hydrochloric acid (HCl) in the stomach lumen. This neutralization reaction modulates the local gastric pH pathway, resulting in an increase in the stomach contents' pH.

---

Osmotic Modulation of Intestinal Fluid Balance

This domain involves the Mg^2+ ions, which are poorly absorbed and remain within the intestinal lumen. Their presence initiates an osmotic gradient, drawing water from the surrounding tissues into the bowel. This fluid shift modulates the intestinal motility system, leading to the physiological effects of increased stool water content and bulk, which mechanically promotes propulsive contractions (peristalsis) in the colon.

Magnesium Hydroxide PSM is designed for oral administration and is supplied in both oral suspension (liquid) and chewable tablet forms. For the liquid formulation, the product must be shaken well prior to measurement to ensure content uniformity, and the dose must be measured using a specifically marked dosing device.

The administration guidelines establish two distinct dosing regimens based on the intended application. When used as an antacid for acid indigestion, single adult doses typically range from 400 mg to 1200 mg of magnesium hydroxide and may be repeated up to four times per day as needed, with a 24-hour maximum intake of 4800 mg. For its use as a laxative to address occasional constipation, the adult dose is higher, ranging from approximately 2400 mg to 7200 mg per day. This laxative dose is typically taken once daily or may be administered in divided portions.

Regardless of the specific application, the medication is strictly intended for short-term, intermittent use. For constipation relief, guidelines indicate that treatment not exceed seven consecutive days. The antacid application should not use the maximum daily dosage for a period longer than two weeks. Furthermore, when taken for its laxative effect, the dose should always be accompanied by a full glass (8 oz) of water or liquid.

Research Evidence / Overview of Studies for Magnesium Hydroxide PSM

---

Evidence for Use as a Saline Laxative: Occasional Constipation

Research for this medicine was studied for occasional constipation primarily using Randomized Controlled Trials (RCTs). These short-term studies were applied in research contexts involving fluctuating or unstable symptoms related to bowel movements. These trials were designed to examine how symptoms change over time and studies explored the medicine against an inactive placebo or other common laxatives, such as lactulose or polyethylene glycol.

Studies monitored various objective outcomes, including spontaneous bowel movement frequency and the time to first bowel movement (laxation response). Research also monitored subjective outcomes related to physical discomfort, such as stool consistency measured using standardized scales. In these studies, findings describe patterns observed in the studies related to changes measured during the study period for these specific outcomes. Despite the existence of multiple trials, the evidence is limited by the short follow-up durations and sample sizes were modest in many comparative trials.

Outcomes and Measures Examined in Laxative Trials

Research has specifically examined outcomes related to systemic or functional imbalance in the digestive tract. The studies explored how symptoms evolved in the observed populations by tracking key indicators like the consistency of the stool and the number of bowel movements over defined time intervals. These specific measurements help to contextualize how patients reported their experience during periods of increased symptom activity.

---

Evidence for Use as an Antacid: Acid-Related Gastric Discomfort

The evidence supporting the medicine was studied for heartburn, sour stomach, and acid indigestion is derived mainly from regulatory standards rather than recent large-scale RCTs. This medicine is recognized as Generally Recognized As Safe and Effective (GRASE) under official Antacid Monographs in certain regulatory regions. The research relevant to this use was studied for conditions characterized by episodic or acute manifestations of gastric acidity.

What is Still Uncertain About the Research Landscape

The research highlights what is known—and what is still uncertain—about the medicine. A key limitation is the methodological heterogeneity across trials for the laxative use, meaning the way studies were designed and conducted varies significantly. The evidence remains rooted in trials and regulatory standards that examine acute or episodic symptom patterns, and little information exists regarding the medicine's role in the long-term management of chronic conditions. This means that the data for these areas are still limited for long-term outcomes and for its use in patient populations that were not directly included in the original regulatory trials.

Key Studies & References

1. Magnesium Hydroxide: MedlinePlus Drug Information (National Library of Medicine)
2. Comparison of the effectiveness of polyethylene glycol 4000 without electrolytes and magnesium hydroxide in the treatment of chronic functional constipation in children - SciELO
3. Evaluation and Treatment of Functional Constipation in Infants and Children: Evidence-Based Recommendations From ESPGHAN and NASPGHAN

Common questions about Magnesium Hydroxide PSM (FAQ)

Q: What is Magnesium Hydroxide PSM used for?

Magnesium Hydroxide PSM (Pharmaceutical Standard Monograph) is primarily used as an antacid to relieve symptoms of heartburn, sour stomach, or acid indigestion. It is also used as a laxative to treat occasional constipation by increasing water in the intestines, which promotes a bowel movement.

---

Q: How quickly does Magnesium Hydroxide PSM work for constipation?

As a laxative, Magnesium Hydroxide PSM typically produces a bowel movement within 30 minutes to 6 hours after taking a dose. The exact time may vary between individuals. It is intended for short-term use to treat occasional constipation.

---

Q: Can Magnesium Hydroxide PSM interact with other medications?

Yes, Magnesium Hydroxide PSM can potentially interact with other medications. It can interfere with the absorption of certain drugs, such as some antibiotics and medications used to treat osteoporosis. To minimize potential interactions, it is generally recommended to take Magnesium Hydroxide PSM at least 2 hours before or after taking other oral medications. Always consult a healthcare provider or pharmacist regarding potential drug interactions.

---

Q: What are common side effects of Magnesium Hydroxide PSM?

When taken at the recommended dose, common side effects of Magnesium Hydroxide PSM are usually mild and may include diarrhea or stomach cramping, particularly when used as a laxative. Less common side effects may include nausea or vomiting.

---

Q: Should Magnesium Hydroxide PSM be taken with food?

Magnesium Hydroxide PSM can generally be taken with or without food. When used as an antacid for heartburn, taking it after meals is often recommended to maximize its acid-neutralizing effect. Follow the specific instructions provided on the product label or by a healthcare professional.

Official Storage and Disposal Requirements

Magnesium Hydroxide must be stored at Controlled Room Temperature, defined as 20 C to 25 C (68 F to 77 F), to maintain product stability. It is a mandatory requirement to protect the product from freezing as this can compromise the stability of the oral suspension.

---

Handling and Safety

Liquid formulations must be kept in a tightly closed container. Certain products are also labeled with the instruction to Protect from light. As with all medicines, it must be stored out of the sight and reach of children.

Disposal

Unused or expired product must be disposed of according to local regulations for pharmaceutical waste. The product is generally not classified as a federally regulated hazardous waste, but local guidelines must always be followed.